Consensus Danaher Corporation

Stocks

DHR

US2358511028

Advanced Medical Equipment & Technology

Market Closed - NYSE 16:02:31 2026-10-19 EDT			5-day change	1st Jan Change
224.43 ^USD	-2.01%		+2.10%	-1.96%

10-19	This week's earnings calendar: CAC stocks, Meta, Tesla, SAP and Nestlé in the spotlight
10-14	JPMorgan Adjusts Price Target on Danaher to $250 From $220	MT

Evolution of the Average Target: Danaher Corporation

Evolution of the Target Price: Danaher Corporation

Changes in Analyst Recommendations: Danaher Corporation

59348aab51c3.60DgoItxILaiKnydU4NjaFcbCHwBkCcUzq_6QNIpe40.jyrR5-09GfX2XkupAuQlWhtUeA5O02FQqdybJZBkMb_bB4vmvzNVw-R7JQ~1c63095d0f3d11a33a58d3b74477acaa

Analysts' recommendations: Danaher Corporation

10-14	JPMorgan Adjusts Price Target on Danaher to $250 From $220	MT
10-13	TD Cowen Adjusts Price Target on Danaher to $255 From $236	MT
10-12	Morgan Stanley Adjusts Price Target on Danaher to $240 From $220	MT
10-08	Baird Adjusts Price Target on Danaher to $246 From $238	MT
10-07	Evercore ISI Adjusts Price Target on Danaher to $240 From $205	MT
10-06	Barclays Adjusts Price Target on Danaher to $255 From $230, Keeps Overweight Rating	MT
10-05	Danaher's Multiple Now in Line With Peers, RBC Says	MT
10-05	RBC Raises Price Target on Danaher to $250 From $215, Keeps Outperform Rating	MT
10-01	Guggenheim Raises Price Target on Danaher to $250 From $200, Keeps Buy Rating	MT
09-21	Goldman Sachs Adjusts Price Target on Danaher to $250 From $210, Maintains Buy Rating	MT
09-21	Analyst recommendations: Flutter, Constellation Brands, CoreWeave, eBay, Meta Platforms…
09-09	Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says	MT
09-03	Baird Adjusts Price Target on Danaher to $238 From $232, Keeps Outperform Rating	MT
09-01	HSBC Adjusts Price Target on Danaher to $250 From $230, Maintains Buy Rating	MT
07-22	Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says	MT
07-22	Deutsche Bank Adjusts Danaher Price Target to $240 From $250, Maintains Buy Rating	MT
07-22	Morgan Stanley Adjusts Price Target on Danaher to $220 From $255, Maintains Overweight Rating	MT
07-22	Wells Fargo Adjusts Price Target on Danaher to $195 From $212, Maintains Equalweight Rating	MT
07-22	Stifel Adjusts Price Target on Danaher to $220 From $260, Maintains Buy Rating	MT
07-22	Jefferies Adjusts Price Target on Danaher to $210 From $245, Maintains Buy Rating	MT
07-22	Guggenheim Adjusts Price Target on Danaher to $200 From $235, Maintains Buy Rating	MT
07-22	TD Cowen Adjusts Price Target on Danaher to $236 From $240, Maintains Buy Rating	MT
07-22	Goldman Sachs Adjusts Price Target on Danaher to $210 From $230, Maintains Buy Rating	MT
07-22	Leerink Partners Adjusts Price Target on Danaher to $240 From $270, Maintains Outperform Rating	MT
07-21	RBC Raises Danaher Price Target to $215 From $200	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DANAHER CORPORATION					+6.59%
	THERMO FISHER SCIENTIFIC, INC.					+0.09%
	INTUITIVE SURGICAL, INC.					+12.15%
	BOSTON SCIENTIFIC CORPORATION					+33.46%
	SIEMENS HEALTHINEERS AG					+9.52%
	VEEVA SYSTEMS INC.					-4.29%
	EDWARDS LIFESCIENCES CORPORATION					+17.56%
	AGILENT TECHNOLOGIES, INC.					+4.67%
	WATERS CORPORATION					+6.26%
	ILLUMINA, INC.					-8.19%
	Average					+7.78%
	Weighted average by Cap.					+6.99%